Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Immune Design Corp. (IMDZ)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/12/2019 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 04/09/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/04/2019 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 75,000 shares
@ $5.85, valued at
$438.8k
Disposed/sold 10,000 options to buy
@ $5.6, valued at
$56k
Disposed/sold 12,500 options to buy
@ $4.05, valued at
$50.6k
Disposed/sold 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 04/04/2019 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 78,287 shares
@ $5.85, valued at
$458k
Disposed/sold 3,058 options to buy
@ $1.48, valued at
$4.5k
Disposed/sold 4,281 options to buy
@ $1.23, valued at
$5.3k
Disposed/sold 10,000 options to buy
@ $5.6, valued at
$56k
Disposed/sold 12,500 options to buy
@ $4.05, valued at
$50.6k
Disposed/sold 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 04/04/2019 |
4
| Yurasov Sergey (Sr. VP, Clinic. Devel. & CMO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 6,136 shares
@ $5.85, valued at
$35.9k
Disposed/sold 72,620 restricted stock units
@ $0
Disposed/sold 110,000 options to buy
@ $4.05, valued at
$445.5k
Disposed/sold 113,335 options to buy
@ $4.4, valued at
$498.7k
Disposed/sold 110,000 options to buy
@ $1.31, valued at
$144.1k
|
|
| 04/04/2019 |
4
| Brady Stephen R (EVP, Strategy & Finance) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 17,063 shares
@ $5.85, valued at
$99.8k
Disposed/sold 79,536 restricted stock units
@ $0
Disposed/sold 116,819 options to buy
@ $1.23, valued at
$143.7k
Disposed/sold 100,000 options to buy
@ $4.05, valued at
$405k
Disposed/sold 184,364 options to buy
@ $4.4, valued at
$811.2k
Disposed/sold 120,000 options to buy
@ $1.31, valued at
$157.2k
|
|
| 04/04/2019 |
4
| Gombotz Wayne (Chief Development Officer) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 37,068 shares
@ $0
Disposed/sold 38,715 options to buy
@ $1.31, valued at
$50.7k
Disposed/sold 6,116 options to buy
@ $1.48, valued at
$9.1k
Disposed/sold 40,697 options to buy
@ $1.23, valued at
$50.1k
Disposed/sold 32,083 options to buy
@ $5.6, valued at
$179.7k
Disposed/sold 11,407 options to buy
@ $4.4, valued at
$50.2k
|
|
| 04/04/2019 |
4
| Paya Carlos V (President and CEO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 35,576 shares
@ $5.85, valued at
$208.1k
Disposed/sold 121,000 restricted stock units
@ $0
Disposed/sold 195,289 options to buy
@ $1.31, valued at
$255.8k
Disposed/sold 67,277 options to buy
@ $1.31, valued at
$88.1k
Disposed/sold 61,161 options to buy
@ $1.48, valued at
$90.5k
Disposed/sold 244,648 options to buy
@ $1.23, valued at
$300.9k
Disposed/sold 175,000 options to buy
@ $5.6, valued at
$980k
Disposed/sold 216,500 options to buy
@ $4.05, valued at
$876.8k
Disposed/sold 263,009 options to buy
@ $4.4, valued at
$1.2M
Disposed/sold 293,000 options to buy
@ $1.31, valued at
$383.8k
|
|
| 04/04/2019 |
4
| ter Meulen Jan Henrik (Chief Scientific Officer) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 14,620 shares
@ $5.85, valued at
$85.5k
Disposed/sold 69,362 restricted stock units
@ $0
Disposed/sold 98,837 options to buy
@ $1.23, valued at
$121.6k
Disposed/sold 70,000 options to buy
@ $5.6, valued at
$392k
Disposed/sold 90,000 options to buy
@ $4.05, valued at
$364.5k
Disposed/sold 46,788 options to buy
@ $4.4, valued at
$205.9k
Disposed/sold 120,000 options to buy
@ $1.31, valued at
$157.2k
|
|
| 04/04/2019 |
4
| Kelley Susan L. (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 10,000 options to buy
@ $5.6, valued at
$56k
Disposed/sold 12,500 options to buy
@ $4.05, valued at
$50.6k
Disposed/sold 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 04/04/2019 |
4
| PENHOET EDWARD (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 3,058 options to buy
@ $1.48, valued at
$4.5k
Disposed/sold 4,281 options to buy
@ $1.23, valued at
$5.3k
Disposed/sold 10,000 options to buy
@ $5.6, valued at
$56k
Disposed/sold 12,500 options to buy
@ $4.05, valued at
$50.6k
Disposed/sold 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 04/04/2019 |
4
| RINGO WILLIAM R (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 10,000 options to buy
@ $5.6, valued at
$56k
Disposed/sold 12,500 options to buy
@ $4.05, valued at
$50.6k
Disposed/sold 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 04/04/2019 |
4
| COLEMAN LEWIS W (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 175,000 shares
@ $5.85, valued at
$1M
Disposed/sold 3,000 shares
@ $5.85, valued at
$17.6k
Disposed/sold 10,000 options to buy
@ $5.6, valued at
$56k
Disposed/sold 12,500 options to buy
@ $4.05, valued at
$50.6k
Disposed/sold 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 04/02/2019 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Unknown transaction of 6,642,942 shares
@ $5.85, valued at
$38.9M
|
|
| 04/02/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/02/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/02/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/02/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/02/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/02/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/02/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/02/2019 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 04/02/2019 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/02/2019 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/28/2019 |
10-K/A
| Annual Report for the period ended December 31, 2018 [amend] |
| 03/26/2019 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/20/2019 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Civitas, Entegra, and Immune Design on Behalf of Stockholders and Encourages Investors to Contact the Firm |
| 03/15/2019 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/15/2019 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/13/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 03/11/2019 |
SC 13G/A
| EcoR1 Capital, LLC reports a 0% stake in Immune Design Corp. |
| 03/05/2019 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 03/05/2019 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 02/28/2019 |
SC 13D/A
| Versant Venture Capital III, L.P. reports a 4.6% stake in IMMUNE DESIGN CORP. |
|
|
|